rs12494849
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006030.4(CACNA2D2):c.207-10928G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.293 in 152,158 control chromosomes in the GnomAD database, including 9,286 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.29 ( 9286 hom., cov: 33)
Consequence
CACNA2D2
NM_006030.4 intron
NM_006030.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.31
Publications
5 publications found
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
CACNA2D2 Gene-Disease associations (from GenCC):
- cerebellar atrophy with seizures and variable developmental delayInheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- complex neurodevelopmental disorderInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.601 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNA2D2 | NM_006030.4 | c.207-10928G>C | intron_variant | Intron 1 of 37 | ENST00000424201.7 | NP_006021.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA2D2 | ENST00000424201.7 | c.207-10928G>C | intron_variant | Intron 1 of 37 | 1 | NM_006030.4 | ENSP00000390329.2 | |||
| CACNA2D2 | ENST00000423994.6 | c.207-10928G>C | intron_variant | Intron 1 of 38 | 5 | ENSP00000407393.2 | ||||
| CACNA2D2 | ENST00000266039.7 | c.207-10928G>C | intron_variant | Intron 1 of 37 | 1 | ENSP00000266039.3 | ||||
| CACNA2D2 | ENST00000360963.7 | c.-1-10928G>C | intron_variant | Intron 1 of 37 | 1 | ENSP00000354228.3 |
Frequencies
GnomAD3 genomes AF: 0.293 AC: 44518AN: 152040Hom.: 9251 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
44518
AN:
152040
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.293 AC: 44613AN: 152158Hom.: 9286 Cov.: 33 AF XY: 0.293 AC XY: 21828AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
44613
AN:
152158
Hom.:
Cov.:
33
AF XY:
AC XY:
21828
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
22263
AN:
41466
American (AMR)
AF:
AC:
5848
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
372
AN:
3470
East Asian (EAS)
AF:
AC:
3195
AN:
5164
South Asian (SAS)
AF:
AC:
620
AN:
4822
European-Finnish (FIN)
AF:
AC:
1566
AN:
10614
Middle Eastern (MID)
AF:
AC:
46
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10023
AN:
68006
Other (OTH)
AF:
AC:
543
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1350
2699
4049
5398
6748
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1160
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.